Increased endometrial cancer risk for BRCA1/2 mutation carriers. Another reason to discuss hysterectomy at time of preventive bilateral salpingo-oophorectomy for these women. Congratulations to the HEBON group on this important study. academic.oup.com/jnci/article/1…

Congratulations to Dr Tamara Hettipathirana who undertook this practice- changing research as her MD research project. It is safe to omit CBE in BRCA1/2 mutation carriers undergoing MRI breast screening- facilitating Telehealth for those who choose. Outstanding work! Centre for Health Services Research in Cancer

The Penny Taylor Oration, a community forum to improve awareness & action on #ovariancancer will be live streamed this Thurs Sept 23, 12pm Honoured to co-host with Kylie Gorringe Liz Christie @DaleGarsed George Auyeung and to introduce KEYNOTE SPEAKER Clare Scott tickets⬇️

We understand no one needs to make you aware of breast cancer. We post this for all the survivors, the caregivers, advocates, the grieving, dedicated doctors and researchers, and especially everyone we’ve lost and continue to mourn.

October is #BreastCancerAwarenessMonth and our incredible team of specialist #breastcancer nurses will be discussing everything you should know over the month, including at a free webinar on October 28. Find out more: petermac.org/news/breast-ca…

“Within relationships of care, clinicians notice the patient’s situation in “high definition,” and co-create a sensible and minimally disruptive plan of care with each patient, acting with compassion and competence. “ 💯% this bmj.com/content/375/bm…

Hey Twitter, I’m seeking an experienced Personal Assistant to join my dynamic and passionate team focussed on cancer prevention. Applications are open now! seek.com.au/job/56144531

🚨Why isn’t ovarian toxicity assessed in breast ca trials? ❗️Clinicians,consumers,pharma, regulatory agencies report ovarian tox is not prioritised during trial design ‼️Ovarian tox info is needed for decision making ✅ We need guidelines and advocacy doi.org/10.1016/j.brea…

A clear reminder to all of us designing cancer clinical trials - don’t forget to collect data on the effect of new anti-cancer drugs on women’s ovarian function! Congratulations ⁦Wanda (Wanyuan) Cui⁩ and ⁦Louise Keogh⁩ for leading this important work thebreastonline.com/article/S0960-…

Australian women have spoken. Loudly. theguardian.com/australia-news…

Eye-opening survey on why physician-industry COI is so common. A "majority simultaneously believed that interactions could influence prescribing while denying influence on their own prescribing" In other words, docs are... ascopubs.org/doi/10.1200/OP… JCO Oncology Practice Peter B. Bach, MD

One of the humblest, most generous researchers I know. Congratulations Prue, from one of the many whose careers you have quietly facilitated.

Well worth a look. Professor Coles is a leading clinical trialist and an excellent communicator. Great at distilling complex information and making it simple.

➡️today Nature Cancer 1. we show in a preclinical model how checkpoint inhibitors can cause ovarian inflammation potentially affecting #fertility #bcsm OncoAlert Gr8 work w @Huttlab 🙏 Sneha Sant @Lauren_Alesi amy winship Peter Mac Research Monash Biomedicine Discovery Institute 👉rdcu.be/cUlAA

Looking forward to discussing the latest advances in hereditary breast cancer with Annabel Crabb Geoff Lindeman Milita Zaheed and Karen Alexander. Breast Cancer Trials Breast Cancer Trials is leading ground-breaking research in this area. Don’t miss it!

Missed our Q&A this week on the topic of Breast Cancer and Genetics? Here's a link to watch the recording of this fantastic discussion. Thanks to our wonderful panel of speakers for their thoughtful insights and advice. youtube.com/watch?v=QbJhJQ…

Online in Annals of Oncology updated ESMO - Eur. Oncology guidelines on risk reduction and screening of #cancer in hereditary breast-ovarian cancer syndromes: honored to be part of this important work! OncoAlert Università di Genova Ospedale San Martino Genova #UNIGEnonsiferma #bcsm #BRCA annalsofoncology.org/article/S0923-…

So important for every woman to know her breast cancer risk, and act on it.

Congratulations Prachi Bhave. So lovely to see your deep passion, energy and enthusiasm for melanoma research recognised with this important award.

A massively important clinical trial, based on ground breaking science from Professors Lindeman and Visvader and their team at WEHI.